Cargando…
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer
SIMPLE SUMMARY: Gut microbiota is emerging as new diagnostic and prognostic marker and/or therapeutic target to improve the management of cancer. This review aims to summarize microbial signatures that have been associated with digestive and other cancers. We report the clinical relevance of these m...
Autores principales: | Veziant, Julie, Villéger, Romain, Barnich, Nicolas, Bonnet, Mathilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124679/ https://www.ncbi.nlm.nih.gov/pubmed/34063108 http://dx.doi.org/10.3390/cancers13092215 |
Ejemplares similares
-
Microbial markers in colorectal cancer detection and/or prognosis
por: Villéger, Romain, et al.
Publicado: (2018) -
Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in Apc(Min/+) mice
por: Chat, Héloïse, et al.
Publicado: (2023) -
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)
por: Taoum, Christophe, et al.
Publicado: (2022) -
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
por: Villéger, Romain, et al.
Publicado: (2019) -
Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model
por: Salesse, Laurène, et al.
Publicado: (2021)